The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations-Reference-Cited by-同舟云学术

The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations

Published:2022-08 Issue:8 Volume: Page:
ISSN:2687-8941
Container-title:JCO Global Oncology
language:en
Short-container-title:JCO Global Oncology

Author:

Caglevic Christian¹²^ORCID,Rolfo Christian³^ORCID,Gil-Bazo Ignacio⁴^ORCID,Cardona Andrés⁵^ORCID,Sapunar Jorge¹,Hirsch Fred R.⁶^ORCID,Gandara David R.⁷^ORCID,Morgan Gilberto⁸^ORCID,Novello Silvia⁹^ORCID,Garassino Marina-Chiara¹⁰^ORCID,Mountzios Giannis¹¹^ORCID,Leighl Natasha B.¹²^ORCID,Bretel Denisse¹³^ORCID,Arrieta Oscar¹⁴^ORCID,Addeo Alfredo¹⁵^ORCID,Liu Stephen V.¹⁶^ORCID,Corrales Luis¹⁷^ORCID,Subbiah Vivek¹⁸^ORCID,Aboitiz Francisco¹⁹,Villarroel-Espindola Franz¹^ORCID,Reyes-Cosmelli Felipe²,Morales Ricardo¹²,Mahave Mauricio¹²,Raez Luis²⁰,Alatorre Jorge²¹,Santos Edgardo²²^ORCID,Ubillos Luis²³^ORCID,Tan Daniel S.W.²⁴^ORCID,Zielinski Christoph²⁵^ORCID

Affiliation:

1. Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile

2. Clinical Trials Unit, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile

3. Clinical Research Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

4. Universidad de Navarra, Department of Oncology, Pamplona, Spain

5. Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center—CTIC, ONCOLGroup/FICMAC, Bogota, Colombia

6. Center for Thoracic Oncology. Mount Sinai Cancer, Mount Sinai Health System, Icahn School of Medicine, Joe Lowe and Louis Price Professor of Medicine, Tisch Cancer Institute, New York, NY

7. Center for Experimental Therapeutics in Cancer, UC Davis Comprehensive Cancer Center, Translational and Clinical Research Program, University of Hawaii Cancer Center, International Society of Liquid Biopsy, Sacramento, CA

8. Skåne University Hospital, Department of Oncology, Lund, Sweden

9. Oncology Department, AOU San Luigi, University of Turin, Turin, Italy

10. Thoracic Oncology Program, the University of Chicago, Chicago, IL

11. 4th Oncology Department and Clinical Trials Unit Henry Dunant Hospital Center, Athens, Greece

12. Medical Oncology Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, IHPME, Dalla Lana School of Public Health, Toronto, Canada

13. GECOPERU, Lima, Peru

14. Toracic Oncology Unit, Instituto Nacional de Cancerologia de Mexico, Mexico City, Mexico

15. Oncology department, University Hospital Geneva, Geneva, Switzerland

16. Lombardi Comprehensive Cancer Center of Georgetown University, Washington, DC

17. Centro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica

18. Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, Medical Oncology Research, MD Anderson Cancer Network, Clinical Center For Targeted Therapy, Division of Pediatrics UT MD Anderson Cancer Center, Houston, TX

19. Centro Interdisciplinario de Neurociencias, Facultad de Medicina, Pontificia Universidad Católica, Santiago, Chile

20. Memorial Cancer Institute/Memorial Health Care System, MCIFAU Florida Cancer Center of Excellence, Florida International University, Miami, FL

21. Instituto Nacional de Enfermedades Respiratorias (INER) Clínica de Oncología Torácica, México D.F., Mexico

22. Florida Precision Oncology/a Division of Genesis Care USA, Research Services Thoracic and Head/Neck Cancer Programs Clinical, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL

23. Instituto Nacional del Cancer, Montevideo, Uruguay

24. Department of Medical Oncology, National Cancer Centre Singapore, Singapore

25. Central European Cancer Center, Wiener Privatklinik, Vienna, and Central European Cooperative Oncology Group, HQ, Vienna, Austria

Abstract

On February 24, 2022, a war began within the Ukrainian borders. At least 3.0 million Ukrainian inhabitants have already fled the country. Critical infrastructure, including hospitals, has been damaged. Children with cancer were urgently transported to foreign countries, in an effort to minimize interruption of their life-saving treatments. Most adults did not have that option. War breeds cancer—delaying diagnosis, preventing treatment, and increasing risk. We project that a modest delay in care of only 4 months for five prevalent types of cancer will lead to an excess of over 3,600 cancer deaths in the subsequent years. It is critical that we establish plans to mitigate that risk as soon as possible.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/GO.22.00123

Reference26 articles.

1. Cancer Incidence in Atomic Bomb Survivors. Part II: Solid Tumors, 1958-1987

2. Agent Orange exposure and cancer incidence in Korean Vietnam veterans: A prospective cohort study

3. Increased risk of head and neck cancer in Agent Orange exposed Vietnam Era veterans

4. Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident

5. Trend in Cancer Incidence and Mortality in Fukushima From 2008 Through 2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel hybrid benzoisothiazole-1,2,3-triazole-4-carboxamides with sub-micromolar toxicity towards human breast carcinoma cells and high affinity to DNA;Journal of Molecular Structure;2024-10

2. Assessment of psycho-oncology in the Middle East and North Africa region: a systematic review and meta-analysis;The Oncologist;2024-08-13

3. An educational approach to develop intercultural nursing care for refugees from Ukraine: A qualitative study;International Nursing Review;2024-07-02

4. Radiation Therapy Delivery During the 2023 Israel-Hamas War: Trust Prevails Over Fear;Advances in Radiation Oncology;2024-07

5. Barriers to access to cancer care for patients from the conflict-affected region of the Nagorno-Karabakh Republic: A qualitative study;PLOS Global Public Health;2024-07-01